Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA
Open Access
- 27 March 2018
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 55 (11) , 8728-8737
Abstract
Alpha synuclein (α-syn) is central to the pathogenesis of a group of neurodegenerative disorders known as synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Aggregation of α-syn is the pathologic hallmark of these disorders and is intimately associated with the pathogenic changes. The prion-like hypothesis postulates that the aggregated α-syn provides a template to seed the aggregation of normal α-syn and spread the pathology. Thus far, it remains unclear whether aggregated α-syn can be a useful biomarker for diagnosis and/or tracking disease progression, which is mainly due to the lack of a suitable biochemical assay. The protein misfolding cyclic amplification (PMCA) technique is known for its enormous amplification power to detect the seeding activity of protein aggregates such as prions. In this study, we adapted PMCA for detecting the seeding activity of α-syn. By extensively optimizing the PMCA parameters, we developed a protocol that is able to sensitively and quantitatively detect the seeding activity of as little as 100 attomoles (10−16 mol) of α-syn aggregate. Using our protocol, we detected α-syn seeding activity from a histologically positive, formaldehyde-fixed MSA sample, but not with the histologically negative, formaldehyde-fixed control sample. Our results confirmed that the α-syn in MSA patient’s brain does contain seeding activity, which remains active even after fixation. Moreover, we also established that PMCA with sonication is a sensitive and quantitative method for detecting α-syn seeding activity, which can be further adapted to more accessible patients’ samples to evaluate α-syn aggregates as a biomarker for synucleinopathies.Keywords
Funding Information
- National Institutes of Health (R21NS101676, R01NS060729)
This publication has 51 references indexed in Scilit:
- Parkinson's Disease Is Not Simply a Prion DisorderJournal of Neuroscience, 2017
- Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synucleinActa Neuropathologica Communications, 2015
- Aβ seeds resist inactivation by formaldehydeActa Neuropathologica, 2014
- Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregatesNature Protocols, 2014
- In vitro aggregation assays for the characterization of α-synuclein prion-like propertiesPrion, 2014
- The many faces of α-synuclein: from structure and toxicity to therapeutic targetNature Reviews Neuroscience, 2012
- Sensitive detection of pathological prion protein by cyclic amplification of protein misfoldingNature, 2001
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988